Ledger.Open graph →
SEC Form D · filed August 26, 2021

Can-Fite BioPharma Ltd

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PETACH TIKVA, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Yaacov Goldman · Yokne'am Illit, L3DirectorIlan Cohn · Petach Tikva, L3DirectorGuy Regev · Petach Tikva, L3DirectorMotti Farbstein · Petach Tikva, L3ExecPnina Fishman · Petach Tikva, L3Exec · DirectorAbraham Sartani · Petach Tikva, L3DirectorTerry Ransford · Chicago, ILDirectorJanon Costly · Washington, Washington, D.C.DirectorYoseph Borenstein · Petach Tikva, L3DirectorTacey R. Viegas · Madison, ALExec · DirectorKevin J. Ritterman · Fargo, NDExecBarbara M. Fisk · Madison, ALDirectorJames R. Hudson, Jr · Huntsville, ALDirectorMichael J. Mcvean · Dallas, TXDirectorSteven Eisner · San Francisco, CADirectorYoseph Borenstein · Petach Tikva, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗